Loading…
Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma
Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against va...
Saved in:
Published in: | BMC complementary medicine and therapies 2024-07, Vol.24 (1) |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 1 |
container_start_page | |
container_title | BMC complementary medicine and therapies |
container_volume | 24 |
creator | Nittayananta, Wipawee Srichana, Teerapol Chuerduangphui, Jureeporn Hitakomate, Ekarat Netsomboon, Kesinee |
description | Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma |
doi_str_mv | 10.1186/s12906-024-04450-0 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A802067248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A802067248</galeid><sourcerecordid>A802067248</sourcerecordid><originalsourceid>FETCH-LOGICAL-g988-463bacbf5dbee09d6724c1678d3eda30f867d2bce4c5b7bbb3e5a4939972c3e53</originalsourceid><addsrcrecordid>eNptkMtqwzAQRUVpoSHND3QlKO1OqR62JC9D6AsC3WRXShg97KjIVmrZ_1-HZpFCmYG5M5x7F4PQLaNLxrR8zIxXVBLKC0KLoqSEXqAZl5ITJRW7PNPXaJHzF6WUCyaUKGfIPae-HSMMIXU41Zjd4w-Ihz18kha6JuUhdHjq1IOB7HHj47S60fqM4ZAOQ8ohn4CI8_cIbRoztj5GbKG3oUst3KCrGmL2i9Oco-3z03b9SjbvL2_r1YY0ldakkMKANXXpjPe0clLxwjKptBPegaC1lspxY31hS6OMMcKXUFSiqhS3kxZzdPcb20D0u9DVaejBtiHb3UpTTo-BeqKW_1BTOd8Gmzpfh-n-x_BwZth7iMM-pzgeX5bPwR8APnZU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Nittayananta, Wipawee ; Srichana, Teerapol ; Chuerduangphui, Jureeporn ; Hitakomate, Ekarat ; Netsomboon, Kesinee</creator><creatorcontrib>Nittayananta, Wipawee ; Srichana, Teerapol ; Chuerduangphui, Jureeporn ; Hitakomate, Ekarat ; Netsomboon, Kesinee</creatorcontrib><description>Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma</description><identifier>ISSN: 2662-7671</identifier><identifier>EISSN: 2662-7671</identifier><identifier>DOI: 10.1186/s12906-024-04450-0</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Alternative medicine ; Antiviral agents ; Apoptosis ; Biological products industry ; Cancer ; Care and treatment ; Ethylenediaminetetraacetic acid ; Health aspects ; Nitric oxide ; Papillomavirus infections ; Prevention ; Squamous cell carcinoma ; Wounds and injuries</subject><ispartof>BMC complementary medicine and therapies, 2024-07, Vol.24 (1)</ispartof><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Nittayananta, Wipawee</creatorcontrib><creatorcontrib>Srichana, Teerapol</creatorcontrib><creatorcontrib>Chuerduangphui, Jureeporn</creatorcontrib><creatorcontrib>Hitakomate, Ekarat</creatorcontrib><creatorcontrib>Netsomboon, Kesinee</creatorcontrib><title>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</title><title>BMC complementary medicine and therapies</title><description>Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma</description><subject>Alternative medicine</subject><subject>Antiviral agents</subject><subject>Apoptosis</subject><subject>Biological products industry</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Health aspects</subject><subject>Nitric oxide</subject><subject>Papillomavirus infections</subject><subject>Prevention</subject><subject>Squamous cell carcinoma</subject><subject>Wounds and injuries</subject><issn>2662-7671</issn><issn>2662-7671</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptkMtqwzAQRUVpoSHND3QlKO1OqR62JC9D6AsC3WRXShg97KjIVmrZ_1-HZpFCmYG5M5x7F4PQLaNLxrR8zIxXVBLKC0KLoqSEXqAZl5ITJRW7PNPXaJHzF6WUCyaUKGfIPae-HSMMIXU41Zjd4w-Ihz18kha6JuUhdHjq1IOB7HHj47S60fqM4ZAOQ8ohn4CI8_cIbRoztj5GbKG3oUst3KCrGmL2i9Oco-3z03b9SjbvL2_r1YY0ldakkMKANXXpjPe0clLxwjKptBPegaC1lspxY31hS6OMMcKXUFSiqhS3kxZzdPcb20D0u9DVaejBtiHb3UpTTo-BeqKW_1BTOd8Gmzpfh-n-x_BwZth7iMM-pzgeX5bPwR8APnZU</recordid><startdate>20240720</startdate><enddate>20240720</enddate><creator>Nittayananta, Wipawee</creator><creator>Srichana, Teerapol</creator><creator>Chuerduangphui, Jureeporn</creator><creator>Hitakomate, Ekarat</creator><creator>Netsomboon, Kesinee</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20240720</creationdate><title>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</title><author>Nittayananta, Wipawee ; Srichana, Teerapol ; Chuerduangphui, Jureeporn ; Hitakomate, Ekarat ; Netsomboon, Kesinee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g988-463bacbf5dbee09d6724c1678d3eda30f867d2bce4c5b7bbb3e5a4939972c3e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alternative medicine</topic><topic>Antiviral agents</topic><topic>Apoptosis</topic><topic>Biological products industry</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Health aspects</topic><topic>Nitric oxide</topic><topic>Papillomavirus infections</topic><topic>Prevention</topic><topic>Squamous cell carcinoma</topic><topic>Wounds and injuries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nittayananta, Wipawee</creatorcontrib><creatorcontrib>Srichana, Teerapol</creatorcontrib><creatorcontrib>Chuerduangphui, Jureeporn</creatorcontrib><creatorcontrib>Hitakomate, Ekarat</creatorcontrib><creatorcontrib>Netsomboon, Kesinee</creatorcontrib><jtitle>BMC complementary medicine and therapies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nittayananta, Wipawee</au><au>Srichana, Teerapol</au><au>Chuerduangphui, Jureeporn</au><au>Hitakomate, Ekarat</au><au>Netsomboon, Kesinee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</atitle><jtitle>BMC complementary medicine and therapies</jtitle><date>2024-07-20</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><issn>2662-7671</issn><eissn>2662-7671</eissn><abstract>Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12906-024-04450-0</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2662-7671 |
ispartof | BMC complementary medicine and therapies, 2024-07, Vol.24 (1) |
issn | 2662-7671 2662-7671 |
language | eng |
recordid | cdi_gale_infotracmisc_A802067248 |
source | Publicly Available Content Database; PubMed Central |
subjects | Alternative medicine Antiviral agents Apoptosis Biological products industry Cancer Care and treatment Ethylenediaminetetraacetic acid Health aspects Nitric oxide Papillomavirus infections Prevention Squamous cell carcinoma Wounds and injuries |
title | Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20of%201%25%20%5Balpha%5D-mangostin%20in%20orabase%20gel%20induces%20apoptosis%20in%20oral%20squamous%20cell%20carcinoma&rft.jtitle=BMC%20complementary%20medicine%20and%20therapies&rft.au=Nittayananta,%20Wipawee&rft.date=2024-07-20&rft.volume=24&rft.issue=1&rft.issn=2662-7671&rft.eissn=2662-7671&rft_id=info:doi/10.1186/s12906-024-04450-0&rft_dat=%3Cgale%3EA802067248%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g988-463bacbf5dbee09d6724c1678d3eda30f867d2bce4c5b7bbb3e5a4939972c3e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A802067248&rfr_iscdi=true |